Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-11-006517
Filing Date
2011-02-10
Accepted
2011-02-10 20:36:16
Documents
1
Period of Report
2011-02-08

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 15714
  Complete submission text file 0001104659-11-006517.txt   17701
Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HBM BIOVENTURES (CAYMAN) LTD. CENTENNIAL TOWERS,STE.305,2454 W.BAY RD. GRAND CAYMAN E9 E9
Business Address
Wicki Andreas (Reporting) CIK: 0001511472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 11594634